Every founder says they want visibility, traction, and growth. But with just 10 tables left and 5 days to grab one, the window to make that happen at TechCrunch Disrupt 2025 is closing fast. If you’ve been thinking about joining 10,000+ startup and VC leaders in San Francisco on October 27–29, this is your moment. […]
5 days left: Exhibit tables are disappearing for Disrupt 2025 Read More »
Billionaire entrepreneur and investor Mark Cuban thinks America’s healthcare industry is broken, and he’s not mincing words about it. “No one looks at the financial side of healthcare and says, ‘This is the way it should work,’” Cuban said on this week’s episode of the Equity podcast. “When you go to the doctor and you
Steve Jobs once said, “Everything’s a remix.” And that’s a philosophy that Mark Cuban has taken to heart, building an entire entrepreneurial and investment career on that simple belief. The real opportunity, Cuban says, lies in spotting patterns others miss and turning them into billion-dollar disruptions. On today’s episode of Equity, Cuban joined TechCrunch’s Rebecca
From streaming to healthcare to AI, Mark Cuban reveals his ‘disruption formula’ Read More »
Alphabet’s life sciences arm Verily laid off staff and eliminated its entire devices program Monday. CEO Stephen Gillett announced the “difficult decision” to wind down the program in a staff memo, according to Business Insider. “Over the years, Verily has built a legacy in developing world-class, innovative medical devices,” Gillett wrote, noting that the “path
Verily is closing its medical device program as Alphabet shifts more resources to AI Read More »
Linda Yaccarino’s next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive
Linda Yaccarino joins health tech platform eMed as CEO after leaving X Read More »
A California jury has found Meta in violation of state user privacy laws in a class-action suit brought by users of period tracking app, Flo, who alleged that the tech giant collected private menstrual health data without users’ consent and used it for ad-tracking purposes. The plaintiffs, claiming to represent millions of Flo users, had
When Esther Hallam welcomed her daughter, Nara, into the world, she faced the challenge of searching for trustworthy brands that offered high-quality, organic infant formula in the U.S. Despite being available for nearly 160 years, the quality of infant formula options in the U.S. is still lacking, she believes. Many manufacturers opt for skim milk
Therapy chatbots powered by large language models may stigmatize users with mental health conditions and otherwise respond inappropriately or even dangerously, according to researchers at Stanford University. While recent coverage in The New York Times and elsewhere has highlighted the role that ChatGPT may play in reinforcing delusional or conspiratorial thinking, a new paper titled
Study warns of ‘significant risks’ in using AI therapy chatbots Read More »
Pharmaceutical scientists come up against a hard limitation here on Earth: gravity. Varda Space wants to change that. The company has raised a massive new round to turn space into the “ultimate high ground” for the production of critical pharmaceutical components that can be brought back to Earth and used to make finished drugs. The
With Varda Space, leading Silicon Valley players make big bet on making drugs in space Read More »
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO Anne Wojcicki. Following a massive cyberattack in 2023 and a related lawsuit settlement, 23andMe filed for bankruptcy in March, with Wojcicki resigning in order to become an independent
Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe Read More »
